. Author manuscript; available in PMC: 2021 Nov 8.

Published in final edited form as: J Subst Abuse Treat. 2018 Jul 31;94:81–90. doi: 10.1016/j.jsat.2018.07.014

Table A-2.

Cost-effectiveness results using GEE modeling.

Treatment Arm	N	Average total cost of treatment per participant episode (2015$)	Past 30 days abstinent from heroin in 30 days prior to 12-month follow-up (self-reported)		Percentage of participants with a negative opioid urine screen at 12- month follow-up
Treatment Arm	N	Average cost (SE)	Mean effectiveness ± (SE)	Incremental CE ratio (ΔC/ΔE)	Mean effectiveness ± (SE)	Incremental CE ratio (ΔC/ΔE)
TAU	149	$2292	20.0	–	39%	–
TAU		(108.26)		–		–
PCM	146	$2396	20.5	$196	40%	$8317
PCM		(102.64)

Note: Standard errors (SE) are presented in parenthesis.